Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Zacksenhaus, Eldad

Class:IdPerson:3222506
_displayNameZacksenhaus, Eldad
_timestamp2013-03-20 17:47:33
created[InstanceEdit:3222508] Orlic-Milacic, M, 2013-03-20
firstnameEldad
initialE
surnameZacksenhaus
(author)[LiteratureReference:3296375] Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
[LiteratureReference:9009126] mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin function
[LiteratureReference:9660620] A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity
[LiteratureReference:9964111] Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
[Change default viewing format]
No pathways have been reviewed or authored by Zacksenhaus, Eldad (3222506)